Detall de la convocatòria


Objectiu de la convocatòria
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Merck & Co., Inc is a global, research-driven pharmaceutical company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Merck Sharpe & Dohme, or MSD, is the name Merck uses for conducting its business in all other countries outside the United States and Canada.
Característiques principals
The EFSD/MSD European Research Programme on Novel Therapies for Type 2 Diabetes is intended to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes.

Proposals may include but are not limited to:
  • Mechanisms to induce “browning of adipose tissue”
  • Novel targets for improving skeletal muscle or adipose tissue insulin resistance
  • Bile acid biology as it relates to metabolic disease. This includes actions relating to glucose metabolism, lipid metabolism, energy balance and related diseases including diabetes, atherosclerosis and obesity
  • Lipid metabolism as it relates to insulin action
  • Mechanisms of glucose-dependent insulin and glucagon secretion
  • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
    Marta López: Ext.: 1576
    Carol Barnwell: Ext.: 1670
    Convocatòria (URL)
    Applications for an EFSD/MSDgrant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
    Up to Euro 100,000
    The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application.


    European Foundation for the Study of Diabetes (EFSD) European Research Programme on New Targets for Type 2 Diabetes _ EFSD.pdf
    General Regulations _ EFSD.pdf